Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.

Bagheri-Mohammadi S, Alani B, Karimian M, Moradian-Tehrani R, Noureddini M.

Open source

DOI
10.1007/s11033-019-04883-8
Published
2019-05-23
Container
Mol Biol Rep
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11033-019-04883-8,
  title = {Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.},
  author = {Bagheri-Mohammadi S and  Alani B and  Karimian M and  Moradian-Tehrani R and  Noureddini M.},
  year = {2019},
  journal = {Mol Biol Rep},
  doi = {10.1007/s11033-019-04883-8},
  url = {https://doi.org/10.1007/s11033-019-04883-8}
}

RIS

TY  - JOUR
TI  - Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.
AU  - Bagheri-Mohammadi S
AU  -  Alani B
AU  -  Karimian M
AU  -  Moradian-Tehrani R
AU  -  Noureddini M.
PY  - 2019
JO  - Mol Biol Rep
DO  - 10.1007/s11033-019-04883-8
UR  - https://doi.org/10.1007/s11033-019-04883-8
ER  - 

APA

S, B., B, A., M, K., R, M., & M., N. (2019). Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.. Mol Biol Rep. https://doi.org/10.1007/s11033-019-04883-8

Source records